Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of Two Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials

    April 2018 in “ ˜The œJournal of urology/˜The œjournal of urology ”
    Jed Kaminetsky, Seymour Fein, Roger Dmochowski … Alan J. Wein
    Studysummary This study found that SER120 nasal spray significantly improved nocturia symptoms and quality of life compared to placebo in patients 50 years and older, with both tested doses showing efficacy and an acceptable safety profile over a 12-week period.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on auajournals.org →
    Discuss this study in the Community →

    Related research 1

    1. Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of Two Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials ˜The œJournal of urology/˜The œjournal of urology · 2018